| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |